Table 1. Glycated albumin of blood donors (April 2009 to March 2010).
| Sex, age (years) | n (%) | Mean BMI† ± SD | Mean GA ± SD | Donor percentage‡ | ||
|---|---|---|---|---|---|---|
| GA ≥15.6% | GA ≥16.5% | GA ≥18.3% | ||||
| Total | ||||||
| 16–19 | 226,046 (7.2) | 21.7 ± 3.0 | 13.5 ± 1.0 | 1.9 | 0.2 | 0.0 |
| 20–29 | 687,235 (21.9) | 22.1 ± 3.1 | 13.5 ± 1.1 | 2.6 | 0.5 | 0.1 |
| 30–39 | 819,949 (26.1) | 23.1 ± 3.3 | 13.6 ± 1.4 | 3.9 | 1.1 | 0.5 |
| 40–49 | 727,986 (23.2) | 23.5 ± 3.1 | 13.9 ± 1.8 | 7.2 | 2.8 | 1.3 |
| 50–59 | 499,586 (15.9) | 23.6 ± 2.8 | 14.4 ± 2.1 | 13.7 | 6.3 | 2.7 |
| 60–69 | 181,992 (5.8) | 23.6 ± 2.6 | 14.8 ± 2.4 | 20.8 | 10.5 | 4.3 |
| 16–69 | 3,142,794 (100.0) | 23.0 ± 3.2 | 13.8 ± 1.7 | 6.8 | 2.7 | 1.1 |
| Male | ||||||
| 16–19 | 121,260 (5.9) | 22.0 ± 3.2 | 13.3 ± 1.0 | 0.8 | 0.1 | 0.0 |
| 20–29 | 404,260 (19.8) | 22.7 ± 3.2 | 13.2 ± 1.1 | 1.1 | 0.2 | 0.1 |
| 30–39 | 547,316 (26.8) | 23.8 ± 3.2 | 13.4 ± 1.5 | 2.7 | 1.0 | 0.5 |
| 40–49 | 513,474 (25.1) | 24.0 ± 3.0 | 13.8 ± 1.9 | 6.5 | 3.0 | 1.6 |
| 50–59 | 340,405 (16.7) | 23.9 ± 2.7 | 14.3 ± 2.3 | 13.1 | 6.7 | 3.3 |
| 60–69 | 115,000 (5.6) | 23.8 ± 2.5 | 14.8 ± 2.5 | 20.7 | 11.5 | 5.2 |
| 16–69 | 2,041,715 (100.0) | 23.5 ± 3.1 | 13.7 ± 1.8 | 6.0 | 2.8 | 1.4 |
| Female | ||||||
| 16–19 | 104,786 (9.5) | 21.3 ± 2.6 | 13.8 ± 1.0 | 3.2 | 0.4 | 0.0 |
| 20–29 | 282,975 (25.7) | 21.4 ± 2.9 | 13.9 ± 1.1 | 4.7 | 0.8 | 0.1 |
| 30–39 | 272,633 (24.8) | 21.8 ± 3.2 | 13.9 ± 1.3 | 6.5 | 1.4 | 0.3 |
| 40–49 | 214,512 (19.5) | 22.3 ± 3.1 | 14.1 ± 1.5 | 8.9 | 2.5 | 0.7 |
| 50–59 | 159,181 (14.5) | 22.8 ± 2.8 | 14.4 ± 1.8 | 14.9 | 5.3 | 1.5 |
| 60–69 | 66,992 (6.1) | 23.3 ± 2.7 | 14.8 ± 2.2 | 20.9 | 8.8 | 2.7 |
| 16–69 | 1,101,079 (100.0) | 22.0 ± 3.0 | 14.1 ± 1.5 | 8.3 | 2.3 | 0.6 |
†Body mass index (BMI) calculated as weight in kilograms divided by height in meters squared. ‡Percentage of donors with indicated glycated albumin (GA) range within the shown age group.